PMID: 2019237Jan 1, 1991

Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes

Diabetes Research and Clinical Practice
J J CouperL C Harrison

Abstract

Twenty-five children aged 2-14 years (mean age 8.39 +/- 0.78 years) were studied prospectively during the first year after the diagnosis of type 1 diabetes. Of their clinical and metabolic features at diagnosis, only age showed a significant independent relationship with endogenous C-peptide production during the first year. Age was correlated with higher values for basal and stimulated plasma C-peptide at 7-14 days after diagnosis, at 6 months and at 12 months. At diagnosis, age was also associated with a higher value for HbA1c and a lower prevalence of insulin antibodies. C-peptide production peaked at 3 months and thereafter declined. Mean HbA1c and insulin requirement were both minimal at 6 months. At diagnosis, there were significant inverse relationships between basal C-peptide production and both insulin dose and HbA1c and between stimulated C-peptide production and HbA1c. Basal and stimulated C-peptide production were inversely related to insulin dose at 6 and 12 months. Stimulated C-peptide was higher at 12 months in children retaining islet cell antibodies. These findings confirm the importance of age as a predictor of residual beta-cell function in type 1 diabetes and indicate that older children present clinically f...Continue Reading

References

Jan 1, 1978·Diabetes·J Ludvigsson, L G Heding
Dec 1, 1976·Diabetologia·J Ludvigsson, L G Heding

Citations

Feb 1, 1995·Human Immunology·B D TaitM C Honeyman
Jan 11, 2007·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
Aug 1, 1995·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·B D TaitL C Harrison
Feb 1, 2003·Molecular Pathology : MP·M A KellyA H Barnett
Oct 3, 2015·Journal of Diabetes and Its Complications·Pawel NiedzwieckiDorota Zozulinska-Ziolkiewicz
Mar 17, 2015·Diabetologia·Bruce BuckinghamDiabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups
Apr 30, 2003·Diabetes·Carla J GreenbaumImmunology of Diabetes Society
Apr 30, 2003·Diabetes·Pejman Hanifi-MoghaddamHubert Kolb
Dec 6, 2003·Pediatric Diabetes·Arlan L Rosenbloom
Feb 5, 2020·Diabetes Technology & Therapeutics·Pawel NiedzwieckiDorota Zozulinska-Ziolkiewicz
Jul 7, 2011·Paediatrics & Child Health·Lisa LemieuxDanièle Pacaud
Jul 10, 2008·Diabetes/metabolism Research and Reviews·Maria Nordwall, J Ludvigsson

Related Concepts

Islet cell surface antibodies
Autoantibodies
C-Peptide
Diabetes, Autoimmune
Hb A1a-2
Novolin
Insulin Antibodies
Islets of Langerhans
Longitudinal Survey

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.